Good to see this finally happening even though this is all expected.
Frank did alright with Juniper Pharmaceuticals as CEO 2009-2016
https://www.reuters.com/article/us-juniper-pharms-m-a-catalent-idUSKBN1JT0WL
Start date: 08/26/2011 1 End date: 08/14/2018 2 Start price/share: $2.07 3 End price/share: $11.50 4 Dividends collected/share: $0.00 5 Total return: 455.56% 6 Average Annual Total Return: 27.88%
Before that Skyepharma from 2006-2016 ( CEO/Board/Chairman )
https://www.biospace.com/article/releases/skyepharma-plc-makes-senior-appointments-new-ceo-coo-/
Eventually was acquired
https://www.reuters.com/article/us-skyepharma-m-a-vectura-grp-idUSKCN0WI1A9
And Ivax was sold to TEVA before that.
- Forums
- ASX - By Stock
- Ann: Mayne Pharma board renewal and new Chairman
Good to see this finally happening even though this is all...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$4.52 |
Change
-0.090(1.95%) |
Mkt cap ! $384.5M |
Open | High | Low | Value | Volume |
$4.59 | $4.61 | $4.48 | $1.020M | 225.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1463 | $4.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.54 | 859 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1463 | 4.500 |
4 | 5844 | 4.490 |
2 | 859 | 4.480 |
3 | 1859 | 4.470 |
2 | 859 | 4.460 |
Price($) | Vol. | No. |
---|---|---|
4.540 | 859 | 2 |
4.550 | 859 | 2 |
4.560 | 859 | 2 |
4.570 | 859 | 2 |
4.580 | 4352 | 4 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |